NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000055462

Registered date:11/09/2024

Risk factors for recurrence after initial treatment with vonoprazan 20 mg/day in patients with mild reflux esophagitis: A prospective multicenter study

Basic Information

Recruitment status Pending
Health condition(s) or Problem(s) studiedGastroesophageal reflux disease (mild)
Date of first enrollment2024/09/11
Target sample size150
Countries of recruitmentJapan
Study typeObservational
Intervention(s)

Outcome(s)

Primary OutcomeFactors associated with symptom recurrence 2 weeks after discontinuing vonoprazan
Secondary OutcomeFactors associated with symptom recurrence 4 weeks after discontinuation of vonoprazan Factors associated with symptom recurrence 2 or 4 weeks after discontinuation of vonoprazan

Key inclusion & exclusion criteria

Age minimum18years-old
Age maximum90years-old
GenderMale and Female
Include criteria
Exclude criteriaPatients with any of the following conditions will be excluded. 1) Severe reflux esophagitis 2) Non-erosive reflux esophagitis 3) Gastroduodenal ulcer 4) Post-surgery of the upper gastrointestinal tract 5) Use of acid secretion inhibitors (H2 blockers, PPIs, P-CABs) within the past 3 months 6) Use of medications that affect reflux esophagitis or heartburn (analgesics such as Rikkunshito, mosapride citrate, acotiamide, antipsychotics, and NSAIDs) 7) Severe systemic disease 8) Psychiatric disease

Related Information

Contact

public contact
Name Kenta Watanabe
Address 1-1-1 Hondo, Akita, Japan Japan 010-8543
Telephone 018-884-6104
E-mail nabeken@med.akita-u.ac.jp
Affiliation Akita University Graduate School of Medicine Department of Gastroenterology
scientific contact
Name Kenta Watanabe
Address 1-1-1 Hondo, Akita, Japan Japan
Telephone 018-884-6104
E-mail nabeken@med.akita-u.ac.jp
Affiliation Akita University Graduate School of Medicine Department of Gastroenterology